HPQHP Inc.

Our directors and officers (as defined in Exchange Act Rule 16a-1(f)) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. On June 4, 2026, Anneliese Olson, our President of Imaging, Printing & Solutions, adopted a written plan for the sale of up to 170,929 shares of our common stock underlying time-based restricted stock units and shares of our common stock underlying any dividend equivalent units that accrue with respect to such awards. The plan is scheduled to commence on October 29, 2026 and is scheduled to expire on March 31, 2027, or on any earlier date on which all of the shares have been sold. This plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

Our directors and officers (as defined in Exchange Act Rule 16a-1(f)) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. On March 10, 2026, David McQuarrie, our Chief Commercial Officer, adopted a written plan for the sale of up to 94,716 shares of our common stock. The plan is scheduled to commence on June 12, 2026 and is scheduled to expire on December 31, 2026, or on any earlier date on which all of the shares have been sold. This plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

Our directors and officers (as defined in Exchange Act Rule 16a-1(f)) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. On September 4, 2025, Alex Cho, our then President, Personal Systems, adopted a written plan for the sale of up to (i) 86,569 shares of our common stock underlying employee stock options; and (ii) 53,221 shares of our common stock underlying performance adjusted restricted stock units, plus any additional shares that vest based on the achievement of the relevant performance criteria. The plan is scheduled to commence on December 8, 2025 and is scheduled to expire on December 11, 2025, or on any earlier date on which all of the shares have been sold. This plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

Our directors and officers (as defined in Exchange Act Rule 16a-1(f)) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. On December 20, 2024, Chip Bergh, our Chair, adopted a written plan for the sale of up to (i) 48,544 shares of our common stock underlying stock options granted under an equity compensation plan and (ii) 36,024 shares of our common stock underlying time-based restricted stock units. The plan is scheduled to commence on March 21, 2025 and is scheduled to expire on February 11, 2026, or on any earlier date on which all of the shares have been sold. On December 26, 2024, Anneliese Olson, our President of Imaging, Printing & Solutions, adopted a written plan for the sale of up to 21,545 shares of our common stock. The plan is scheduled to commence on March 26, 2025 and is scheduled to expire on April 10, 2025, or on any earlier date on which all of the shares have been sold. These plans are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

Our directors and officers (as defined in Exchange Act Rule 16a-1(f)) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. On December 20, 2024, Chip Bergh, our Chair, adopted a written plan for the sale of up to (i) 48,544 shares of our common stock underlying stock options granted under an equity compensation plan and (ii) 36,024 shares of our common stock underlying time-based restricted stock units. The plan is scheduled to commence on March 21, 2025 and is scheduled to expire on February 11, 2026, or on any earlier date on which all of the shares have been sold. On December 26, 2024, Anneliese Olson, our President of Imaging, Printing & Solutions, adopted a written plan for the sale of up to 21,545 shares of our common stock. The plan is scheduled to commence on March 26, 2025 and is scheduled to expire on April 10, 2025, or on any earlier date on which all of the shares have been sold. These plans are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

Our directors and officers (as defined in Exchange Act Rule 16a-1(f)) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. On March 21, 2024, Alex Cho, our President, Personal Systems, adopted a written plan for the sale of up to (i) 173,137 shares of our common stock underlying employee stock options; (ii) 78,027 shares of our common stock underlying time-based restricted stock units; (iii) 35,630 shares of our common stock underlying performance adjusted restricted stock units, plus any additional shares that vest based on the achievement of the relevant performance criteria; and (iv) shares of our common stock underlying any dividend equivalent units that accrue with respect to these awards. The plan is scheduled to commence on June 21, 2024 and is scheduled to expire on December 31, 2024, or on any earlier date on which all of the shares have been sold. The plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

Our directors and officers (as defined in Exchange Act Rule 16a-1(f)) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. On June 10, 2024, Enrique Lores, our President and Chief Executive Officer, adopted a written plan for the sale of up to (i) 317,252 shares of our common stock underlying employee stock options; (ii) 167,098 shares of our common stock underlying time-based restricted stock units; (iii) 54,221 shares of our common stock underlying performance adjusted restricted stock units, plus any additional shares that vest based on the achievement of the relevant performance criteria; and (iv) shares of our common stock underlying any dividend equivalent units that accrue with respect to these awards. The plan is scheduled to commence on September 12, 2024 and is scheduled to expire on June 30, 2025, or on any earlier date on which all of the shares have been sold. The plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.